Advancing research in molecular biotechnology, bioprocess engineering, biomedical innovation, genomics, bioinformatics, industrial biotechnology and the translation of biological discoveries into applications for human health and society.
The Department of Biotechnology of The Gazette of Medical Sciences (The GMS) publishes peer-reviewed, open-access scholarly work advancing the development and application of biological systems, molecular technologies and bioprocesses across medicine, agriculture, industry and environmental sciences. The Department provides an international platform for biotechnologists, molecular biologists, biochemical engineers, clinicians, computational scientists and allied researchers to communicate discoveries that expand biological understanding and support practical innovation.
The Department welcomes original experimental and applied research, clinical and laboratory investigations, systematic and narrative reviews, case reports, case series, short communications, methodological studies, scholarly opinions, editorials and perspectives. Contributions may address molecular biology, genetic engineering, recombinant DNA technology, cell and tissue engineering, enzyme technology, protein engineering, microbial biotechnology and the design, optimization and evaluation of biological products and processes.
Particular emphasis is placed on medical and pharmaceutical biotechnology, including biotechnology-based diagnostics, vaccines, therapeutic proteins, monoclonal antibodies, biologics, biosimilars, drug discovery, drug-delivery systems, regenerative medicine and advanced therapeutic technologies. The Department encourages research involving molecular targets, biomarkers, diagnostic platforms, biopharmaceutical development, biocompatible materials and biotechnological approaches to infectious, genetic, metabolic, neurological and other diseases.
The Department also encompasses bioprocess engineering, biochemical engineering, fermentation technology, industrial microbiology, bioreactor design, downstream processing, biomanufacturing, quality assessment and the development of new formulations and products. Research in agricultural and food biotechnology, plant biotechnology, microbial applications, food safety, functional foods, biofertilizers, bioremediation, bioenergy and sustainable biotechnology is welcomed where the work contributes to scientific or technological advancement.
Recognizing the growing integration of biotechnology with computational and data-driven sciences, the Department encourages studies in genomics, proteomics, transcriptomics, metabolomics, bioinformatics, systems biology, molecular docking, computational drug discovery, artificial intelligence and biological modeling. Interdisciplinary research addressing biosafety, bioethics, regulatory science, technology transfer, translational development and equitable access to biotechnology is also within scope. The Department seeks to promote reproducible research, responsible innovation and collaboration between laboratory discovery, engineering and real-world applications.
The Department supports scientifically rigorous and ethically conducted biotechnology research, from fundamental laboratory investigations to translational and applied studies. All submissions undergo editorial assessment and peer review in accordance with the journal's applicable editorial and publication policies.
This computational study investigates selected phytochemicals from Carica papaya Linn. as potential ligands of the SARS-CoV-2 main protease. Using molecular docking tools, including AutoDock and PyRx, the researchers evaluated predicted interactions between selected compounds and the viral protein structure. Drug-likeness and absorption, distribution, metabolism and excretion (ADME) properties were also assessed using computational prediction methods. The article discusses compounds including quercetin, luteolin, apigenin, kaempferol and benzylglucosinolate as candidates for further investigation. The findings are exploratory in-silico predictions and do not establish antiviral efficacy or clinical effectiveness against COVID-19.
View / Download Article ↗Please direct any enquiry or submit papers to: info@thegms.co